| Product No | EMEA/H/C/000328 |
|---|---|
| Brand Name | Ixense |
| Nonproprietary Name | apomorphine |
| API | apomorphine hydrochloride |
| ATC Code | G04BE |
| Indications | Treatment of men with erectile dysfunction, which is the inability to achieve or maintain a penile erection sufficient for satisfactory sexual performance.In order for Ixense to be effective, sexual stimulation is required. |
| Orphan Drug | no |
| Generics | no |
| Marketing Authorization Holder | Takeda Europe R Centre Ltd. |
| Status | Withdrawn |
| Authorization Date | 2001-05-28 |
| Version | 0 |
| Condition Approval | no |
| Exceptions | no |
| Biosimilar | no |
| Details | 查看 (公众评估报告、授权细节、产品规格/剂型、标签、历史评估信息) |
Extended Information